- •Preface
- •Contents
- •1.1 Introduction
- •1.2 Basic Principles
- •1.2.1 Formal Definition of Diffusion
- •1.2.2 Pulse Sequence Considerations
- •1.2.3 Diffusion Modelling in GI Cancer
- •1.2.4 Diffusion Biomarkers Quantification
- •1.3 Clinical Applications
- •1.3.1 Whole-Body Diffusion
- •References
- •2: Upper Gastrointestinal Tract
- •2.1 Introduction
- •2.2 Technical Details
- •2.2.1 Patient Preparation/Protocols
- •2.2.2 Image Acquisition
- •2.3 Artefact and Image Optimization
- •2.4 Clinical Applications
- •2.4.1 Upper GI Tract Malignancy
- •2.4.1.1 The Oesophagus
- •2.4.1.2 The Stomach
- •2.4.2 Role of DWI in Treatment Response
- •2.4.3 Other Upper GI Pathologies
- •2.4.3.1 Gastrointestinal Lymphoma
- •2.4.3.2 Stromal Tumours
- •2.4.3.3 Inflammation
- •References
- •3: Small Bowel
- •3.1 Introduction
- •3.2 Prerequisites
- •3.2.1 Patient Preparation
- •3.2.2 Imaging Protocol
- •3.2.3 DWI Analysis
- •3.3 Inflammatory Bowel Disease
- •3.3.1 Crohn’s Disease (CD)
- •3.4 Small Bowel Neoplasms
- •3.4.1 Adenocarcinoma
- •3.4.2 Lymphoma
- •3.4.3 Carcinoids
- •3.4.4 Gastrointestinal Stromal Tumours (GISTs)
- •3.5 Other Small Bowel Pathologies
- •3.5.1 Gluten-Sensitive Enteropathy
- •3.5.2 Vasculitis
- •3.5.3 Therapy-Induced Changes of the Small Bowel
- •3.6 Appendicitis
- •3.7 Summary
- •References
- •4: Large Bowel
- •4.1 Introduction
- •4.2 Technical Considerations
- •4.3 Detection of Polyps and Cancer
- •4.5 Assessment of Inflammatory Bowel Disease
- •4.5.1 Detection of Inflammatory Changes in the Colon
- •4.5.2 Assessment of Disease Activity
- •4.5.3 Evaluation of Response to Therapy
- •4.6 Future Applications and Perspectives
- •References
- •5: Rectum
- •5.1 Introduction
- •5.2 DWI for Primary Rectal Cancer Staging
- •5.2.1 DWI for Rectal Tumour Detection
- •5.2.2 DWI for Rectal Tumour Staging
- •5.2.3 DWI for Lymph Node Staging
- •5.3 DWI for Tumour Restaging After Chemoradiotherapy
- •5.3.1 DWI for Tumour Response Assessment
- •5.3.2 DWI for Mesorectal Fascia Assessment After CRT
- •5.3.3 DWI for Nodal Restaging
- •5.4 DWI for Follow-Up After Treatment
- •5.5 DWI as a Prognostic Marker
- •5.6 Pitfalls in Rectal DWI
- •References
- •6: Anal Canal
- •6.1 Introduction
- •6.2 Locoregional Staging of Anal Cancer (Baseline)
- •6.3 Locoregional Staging of Anal Cancer After Treatment
- •6.4 Perianal Fistula Disease Detection/Road Mapping
- •References
Small Bowel |
3 |
|
|
Sonja Kinner |
|
3.1\ Introduction
Unlike the upper and lower gastrointestinal tract, the diagnostic access to the small bowel is not as easy. Therefore, it is of utmost importance to find a diagnostic tool to evaluate this more “hidden” gastrointestinal part with high sensitivity and specificity. Indeed, capsule endoscopy is now available for diagnosing the small bowel, but this tool is cost-intensive and there are certain contraindications, especially bowel strictures or obstruction [1]. Furthermore, capsule endoscopy only allows visualization of the surface, which is the mucosal layer, and deeper tissues cannot be evaluated, not to mention the surrounding tissues and other abdominal organs. Over the past years, cross-sectional imaging techniques like computed tomography (CT) and magnetic resonance imaging (MRI) have evolved considerably and changed the diagnostic approach of the small bowel. Both techniques are now optimized for small bowel imaging and play a more and more increasing role in the diagnosis of small bowel pathologies. CT is burdened with a still not negligible amount of radiation exposure, which is especially of importance for patients who are to undergo multiple examinations during their life due to the recurrent character of their underlying disease. As a result, MR imaging has become an increasingly used diagnostic tool and nowadays is an important imaging modality for evaluating small bowel pathologies. Besides the already in-place sequences like balanced steady state free precession, T2-weighted images with and without fat saturation and T1-weighted images unenhanced and dynamically acquired after the injection of a gadolinium-based contrast agent, diffusion-weighted imaging (DWI) has gained more and more importance in the last decade within the MR imaging protocol of the small bowel [2]. As DWI relies on the diffusion of water in tissue and
S. Kinner
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
e-mail: sonja.kinner@uk-essen.de
© Springer International Publishing AG, part of Springer Nature 2019 |
33 |
S. Gourtsoyianni, N. Papanikolaou (eds.), Diffusion Weighted Imaging of the Gastrointestinal Tract, https://doi.org/10.1007/978-3-319-92819-7_3